Insider · CIK 0001916666
Stephen D Laxton
Files at NUE (NUCOR CORP). First filing Nov 7, 2024, latest Aug 3, 2026.
In brief
Stephen D Laxton files SEC Form 4 as CFO, COO and president at NUE (NUCOR CORP). Since Nov 7, 2024, Stephen D Laxton has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.1M, the latest filed on Aug 3, 2026.
A track record needs three past buys with six months of prices behind them; Stephen D Laxton has 0, so none is measured yet.
The newest scored trade: sold $1.0M of NUE on Jul 30, 2026, filed Aug 3, 2026, scored 53 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $1.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NUE: NUCOR CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | NUCOR CORP | $1.0M 3,968 shares | -5% | +97% from low-3% from high | |
| 51Moderate | NUCOR CORP | $304k 2,003 shares | -2% | +46% from low-9% from high | |
| 59Moderate | NUCOR CORP | $799k 4,712 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 30, 2026 | NUE NUCOR CORP | 3,968 0.00% of outstanding | $1.0M | Jul 30, 2026 | none |
| Oct 30, 2025 | NUE NUCOR CORP | 2,003 0.00% of outstanding | $304k | Oct 30, 2025 | none |
| Nov 6, 2024 | NUE NUCOR CORP | 4,712 0.00% of outstanding | $799k | Nov 6, 2024 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | NUE NUCOR CORP | GGift Common Stock | -2,409 | $0.00 | $0 | 81,835 | Aug 3, 2026 |
| Jul 30, 2026 | NUE NUCOR CORP | SOpen-market sale Common Stock | -3,968 | $256.96 | $1.0M | 77,867 | Aug 3, 2026 |
| Jun 1, 2026 | NUE NUCOR CORP | FTax withholding Common Stock | -3,048 | $250.00 | $762k | 84,336 | Jun 3, 2026 |
| Jun 1, 2026 | NUE NUCOR CORP | FTax withholding Common Stock | -2,401 | $250.00 | $600k | 81,935 | Jun 3, 2026 |
| Jun 1, 2026 | NUE NUCOR CORP | FTax withholding Common Stock | -1,219 | $250.00 | $305k | 80,716 | Jun 3, 2026 |
| Jun 1, 2026 | NUE NUCOR CORP | AGrant or award Common Stock | +3,528 | $0.00 | $0 | 84,244 | Jun 3, 2026 |
| Jun 1, 2026 | NUE NUCOR CORP | AGrant or award Stock Optionderivative | +4,607 | $0.00 | $0 | 4,607 | Jun 3, 2026 |
| Mar 10, 2026 | NUE NUCOR CORP | AGrant or award Common Stock | +824 | $169.47 | $140k | 87,384 | Mar 12, 2026 |
| Feb 19, 2026 | NUE NUCOR CORP | AGrant or award Common Stock | +5,365 | $0.00 | $0 | 86,560 | Feb 23, 2026 |
| Dec 22, 2025 | NUE NUCOR CORP | FTax withholding Common Stock | -986 | $157.11 | $155k | 87,188 | Dec 23, 2025 |
| Dec 22, 2025 | NUE NUCOR CORP | FTax withholding Common Stock | -3,070 | $157.11 | $482k | 84,118 | Dec 23, 2025 |
| Dec 22, 2025 | NUE NUCOR CORP | FTax withholding Common Stock | -2,923 | $157.11 | $459k | 81,195 | Dec 23, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | GGift Common Stock | -2,061 | $0.00 | $0 | 90,177 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -1,082 | $151.51 | $164k | 89,095 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -15 | $151.53 | $2,273 | 89,080 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -1 | $151.55 | $152 | 89,079 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -25 | $151.56 | $3,789 | 89,054 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -70 | $151.57 | $11k | 88,984 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -257 | $151.62 | $39k | 88,727 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -510 | $151.67 | $77k | 88,217 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -18 | $151.70 | $2,731 | 88,199 | Nov 3, 2025 |
| Oct 30, 2025 | NUE NUCOR CORP | SOpen-market sale Common Stock | -25 | $151.73 | $3,793 | 88,174 | Nov 3, 2025 |
| Jun 1, 2025 | NUE NUCOR CORP | AGrant or award Common Stock | +8,412 | $0.00 | $0 | 98,333 | Jun 3, 2025 |
| Jun 1, 2025 | NUE NUCOR CORP | FTax withholding Common Stock | -613 | $109.36 | $67k | 97,720 | Jun 3, 2025 |
| Jun 1, 2025 | NUE NUCOR CORP | FTax withholding Common Stock | -3,066 | $109.36 | $335k | 94,654 | Jun 3, 2025 |
| Jun 1, 2025 | NUE NUCOR CORP | FTax withholding Common Stock | -2,416 | $109.36 | $264k | 92,238 | Jun 3, 2025 |
| Jun 1, 2025 | NUE NUCOR CORP | AGrant or award Stock Optionderivative | +12,192 | $0.00 | $0 | 12,192 | Jun 3, 2025 |
| Nov 6, 2024 | NUE NUCOR CORP | SOpen-market sale Common Stock | -4,712 | $169.53 | $799k | 82,132 | Nov 7, 2024 |
Questions about Stephen D Laxton
Answered from the filings on this page, as of the latest one.
Is Stephen D Laxton buying or selling?
In the last 12 months Stephen D Laxton reported 0 open-market buys worth $0 and 2 open-market sells worth $1.3M on SEC Form 4; the latest was sold $1.0M of NUE on Jul 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Stephen D Laxton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen D Laxton has 0.
Where does Stephen D Laxton file Form 4?
Stephen D Laxton has filed Form 4 at NUE (NUCOR CORP) as President and COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.